Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a study titled ‘A Phase 2b/3, Randomized, ...
Merck completes $10B acquisition of Verona Pharma, adding Ohtuvayre — the first new inhaled COPD therapy in over 20 years.
New findings from the ERS Global Congress on Lung Diseases present a paradigm shift in COPD treatment: Early identification of type 2 inflammation and personalized biologic therapy.
Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...
Inhaled corticosteroids pose long-term risks in COPD management, prompting careful screening and potential de-escalation ...
Telemedicine significantly improved quality of life and inhaler technique in advanced COPD patients compared to traditional ...
If you start to experience symptoms like chest pain, blue lips, or coughing up more than a teaspoon of blood, you should see ...
Respiratory diseases such as Asthma and Chronic Obstructive Pulmonary Disease (COPD) are on the rise partly because of ...
The FDA granted approval to nerandomilast, now Jascayd, for treating adults with idiopathic pulmonary fibrosis, marking the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback